Nofi, Colleen P.
Prince, Jose M.
Brewer, Mariana R.
Aziz, Monowar
Wang, Ping https://orcid.org/0000-0002-1557-0394
Funding for this research was provided by:
Foundation for the National Institutes of Health (R01GM129633, U01AI170018, R35GM118337, R01HL076179, R01AA028947, U01AI170018)
Article History
Received: 20 May 2024
Accepted: 11 September 2024
First Online: 20 September 2024
Declarations
:
: Human stool samples were studied under the approval of Institutional Review Board (Northwell Health IRB No. 19-0981). All animal studies were performed under the approval of the Institutional Animal Care and Use Committee of the Feinstein Institutes for Medical Research (Protocol No. 2023–005).
: Yes.
: The authors (CN, MA, and PW) are inventors of the pending PCT application on “A chimeric molecule to treat septic patients”; EFS ID: 47240580; Application No.: 63433789. Other authors report no financial competing interests.